Company: ZURA
Filing Date: 2025-05-28
Form Type: SCHEDULE 13D
Source: 0000950170-25-078447
Chunk: 0

Company: Zura Bio Ltd
Filing Date: 2025-05-28
Form: SCHEDULE 13D
Chunk 0
---
 of $4.25 per share. AIB funded these purchases using capital contributed from affiliated entities, which funded that capital using cash on hand. Under the terms of the 2023 Subscription Agreement, the Issuer agreed to prepare and file with the SEC, within 45 days after the closing, a registration statement to register for resale the Class A Ordinary Shares issued under the 2023 Subscription Agreement (the "2023 Class A Ordinary Shares") and the Class A Ordinary Shares issuable upon exercise of the 2023 Warrants (the "2023 Warrant Shares"), and to cause the registration statement to become effective within a specified period after the closing. The Issuer also agreed to use its best efforts to keep such registration statement effective until the earlier of (i) the date on which all of the 2023 Class A Ordinary Shares and 2023 Warrant Shares held by or issuable to AIB may be sold under Rule 144 ("Rule 144") promulgated under the Securities Act of 1933, as amended, without being subject to any volume or manner of sale requirements, (ii) the date on which all of the 2023 Class A Ordinary Shares and 2023 Warrant Shares have actually been sold pursuant to Rule 144 or pursuant to the registration statement and (iii) the date which is two years from the date that the initial registration statement is declared effective (or any Additional Effectiveness Date (as defined in the 2023 Subscription Agreement), if applicable). 
 Between July 18, 2023 and February 9, 2024, AIB purchased 1,952,725 Class A Ordinary Shares in open market transactions for an aggregate purchase price of $9,782,379.15, at prices and on the dates set forth in Schedule A, filed as Exhibit 99.1 hereto. AIB funded these purchases using capital contributed from affiliated entities, which funded that capital using cash on hand.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 On April 18, 2024, AIB purchased from the Issuer 8,046,346 private placement pre-funded warrants, each whole pre-funded warrant entitling AIB to purchase one Class A Ordinary Share for an exercise price equal to $0.001 per share (the "2024 Warrants"), for a purchase price of $3.108 per share, pursuant to a subscription agreement between the Issuer and AIB dated as of April 18, 2024 (